Alfonso Additive
Develops Alfonso Cloud, a particle-based SaaS simulation platform for orthopaedic implant R&D and patient-specific development.
- CEO / Founder
- Sloan Kulper
- Team Size
- 1-10
- Stage
- Active
- Key Investors
- European Regional Development Fund
Technology & Products
Key Products
Alfonso Cloud
Technological Advantage
Proprietary particle-based simulation technology for orthopaedic implants, delivered via a 24/7 SaaS platform and protected by a US patent.
Differentiation
Value Proposition
Reduces R&D time for orthopaedic implants by providing 24/7 self-service access to high-fidelity particle-based simulations.
How They Differentiate
Utilizes a proprietary grain-scale Discrete Element Method (DEM) simulation rather than traditional macro-scale Finite Element Method (FEM); this allows for high-fidelity modeling of individual powder particle behavior, melt pool dynamics, and porosity specifically for complex orthopaedic lattice structures.
Market & Competition
Target Customers
Orthopaedic implant industry
Industry Verticals
Medical; Orthopaedics
Competitors
Ansys (Additive Suite), Materialise (Magics Simulation), Simufact (Hexagon)
Growth & Milestones
Major Milestones
Launched Alfonso Cloud SaaS at AAOS 2022; Exhibited at NASS 2022; Won SGD 28,000 technology prize at Singapore NAMIC Innovation Forum (2023); US patent granted
Notable Customers
Queen Mary Hospital (QMH), Hong Kong; University of Hong Kong (HKU) Faculty of Medicine; Johnson & Johnson (JLABS@Shanghai); NAMIC (National Additive Manufacturing Innovation Center), Singapore; Zimmer Biomet; DePuy Synthes; Dr. med. Kerstin Schneider; AITA – Associazione Italiana Tecnologie Additive; Interreg SI-AT project ADDCIRCLES; Seven of the top 10 global orthopaedic implant manufacturers